Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î]¹Ì±¹, ½Ã´ë ¸ÂÃç ±³À°°ú¸ñ º¯È­¡¦»çÈÄÆò°¡µµ Àǹ«È­
³»   ¿ë

¹Ì±¹, ½Ã´ë ¸ÂÃç ±³À°°ú¸ñ º¯È­¡¦»çÈÄÆò°¡µµ Àǹ«È­

»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ


2020-03-16 06:00:27                 ÁÖÇý¼º ±âÀÚ hsjoo@kpanews.co.kr             

       
    
°æÁ¦¼ºÀå°ú ±×¿¡ µû¸¥ ³ëÀÎÀα¸ÀÇ Áõ°¡, ¸¸¼ºÁúȯÀÇ À¯º´À² Áõ°¡´Â º¸°ÇÀÇ·á¼­ºñ½ºÀÇ ¼ö¿ä¸¦ Áúº´ÀÇ Ä¡·á¿¡¼­ Áúº´ÀÇ °ü¸®·Î º¯È­½Ã۰í ÀÖ´Ù. ÀÌ·¯ÇÑ º¯È­´Â ÀǾàǰ º¹¿ë¿¡ À־µµ º¹¿ë¾à¹° Á¾·ùÀÇ Áõ°¡, º¹¿ë±â°£ÀÇ Àå±âÈ­ µîÀÇ º¯È­¸¦ ÃÊ·¡Çß´Ù. À̴ ÀǾàǰÀÇ Àü¹®°¡ÀΠ¾à»çµé¿¡°Ô ÀǾàǰÀÇ Á¦°ø¿¡¼­ ÀǾàǰ »ç¿ë°ü¸®(¾à·á)·Î ±× ¿ªÇÒÀ» È®´ë, °íµµÈ­ ½Ãų °ÍÀ» ¿ä±¸Çϰí ÀÖ´Ù. ¿ªÇÒÀÇ º¯È­´Â ±×¿¡ ¸Â´Â Àü¹®¼ºÀÌ ¼ö¹ÝµÅ¾ß Çϸç, µû¶ó¼­ º¸°ÇÀÇ·áÀü¹®°¡ ¿¬¼ö±³À° È¿À²È­¿Í À̸¦ ÅëÇÑ ¾àÁ¦¼­ºñ½ºÀÇ Áú °ü¸®´Â ÇʼöÀû »çÇ×ÀÌ µÆ´Ù. 
¿¬¼ö±³À°Àº ¾à»ç¹ý Á¦15Á¶, µ¿¹ý ½ÃÇà·É Á¦35Á¶ ¹× ½ÃÇà±ÔÄ¢ Á¦5Á¶¿¡ ÀǰÅÇØ ´ëÇѾà»çȸ°¡ º¸°Çº¹ÁöºÎ·ÎºÎÅÍ À§Å¹¹Þ¾Æ ½Ç½ÃÇϰí ÀÖÀ¸³ª, ¿¬¼ö±³À°ÀÇ ³»¿ë, ¹æ¹ý, Æò°¡ µî ¿©·¯ ºÐ¾ß¿¡¼­ ¿î¿µ ¹× °¨µ¶Ã¼°èÀÇ ºÎ½Ç¿¡ ´ëÇÑ ¹®Á¦Á¡ÀÌ Á¦±âµÇ°í ÀÖ´Ù. 
µû¶ó¼­ º»°í¿¡¼­´Â ¾à»ç¿¬¼ö±³À° ³»¿ëÀÇ Àü¹®¼ºÀ» È®º¸Çϰí, ±³À° °ü¸®¸¦ È¿À²È­ÇØ ¾àÁ¦¼­ºñ½ºÀÇ ÁúÀû Çâ»óÀ» ±âÇÒ ¼ö Àִ ¹Ù¶÷Á÷ÇÑ ¹æÇâÀ» Á¦½ÃÇØ º¸°íÀÚ ÇÑ´Ù. 
À̸¦ À§ÇØ, ¹Ì±¹, ÀϺ» µî ÁÖ¿ä±¹ÀÇ ¾à»ç¿¬¼ö±³À° ¹× ±¹³» Å¸ ÀÇ·áÀÎÀÇ º¸¼ö±³À°2) ¿î¿µÇöȲ ¹× °ü¸®Ã¼°è¸¦ °íÂûÇß´Ù.

¹Ì±¹ÀÇ ¾à»ç¿¬¼ö±³À°
¡â¹Ì±¹ ¾à»ç¿¬¼ö±³À°°ú CPD
¹Ì±¹¿¡¼­´Â 1975³â ¾à»ç¿¬¼ö±³À° ÀÎÁõ(Accreditation Council for Pharmacy Education, ACPE)ÀÌ ½ÃÀ۵ưí, Àü¹® ´É·Â °³¹ß(Continuing Professional Development, CPD)·Î ¾à»ç¿¬¼ö±³À°ÀÇ °³³äÀÌ È®´ëµÈ °ÍÀº 2015³âºÎÅÍÀÌ´Ù. 

CPD´Â ±âÁ¸ÀÇ ¾à»ç¿¬¼ö±³À°ÀÌ ¾à»çÀÇ ±âÈ£¿¡ ¸Â´Â ÀûÁ¤ ±³À°ÀÌ ¾Æ´Ï¸ç, È¨½ºÅ͵𠱳À°À» ¼±È£Çϴ °æÇâÀ¸·Î ÀÎÇÑ ´ë¸® ¼ö°­ µîÀÇ ¹®Á¦Á¡À» ¾È°í À־ÇÁ¦ ¾à»ç ¾÷¹«¿¡ Å« µµ¿òÀÌ µÇÁö ¾Ê´Â´Ù´Â ¾à»ç »çȸÀÇ °¢¼ºÀ¸·ÎºÎÅÍ ³íÀǵDZ⠽ÃÀÛÇß´Ù. 

CPD´Â ¾à»ç ½º½º·Î ÀÚ½ÅÀÌ ÇÊ¿äÇÑ ºÎºÐ¿¡ ¸Â´Â ¿¬¼ö±³À°À» ¼±ÅÃÇØ ¼ö°­ÇÒ ¼ö Àִ °³ÀΠ¸ÂÃãÇüÀ̶ó´Â °ÍÀÌ °¡Àå Å« ÀåÁ¡ÀÌ´Ù. ¶ÇÇÑ ±³À°¹æ½Ä¿¡ À־µµ °­ÀÇ, ¼¼¹Ì³ª, ÇÐȸ, ¿Â¶óÀΠ±³À° µî ´Ù¾çÈ­µÅ Àִ °ÍÀ̠Ư¡ÀÌ´Ù. 

Áï, ¾à»ç¿¬¼ö±³À°ÀÇ °³³äÀ» ¾à»ç ¿ª·® °­È­¸¦ Áß½ÉÀ¸·Î °³ÆíÇϸ鼭 ÀÚ±âÁÖµµÀû ÇнÀÀÌ °­È­?¹ßÀüµÇ°í Àִ °ÍÀÌ´Ù.3)



¡â¿î¿µ ±â°ü ¹× ±¸Á¶
¹Ì±¹ ¾à»ç¿¬¼ö±³À°Àº ÁÖº°·Î Â÷À̰¡ ÀÖÁö¸¸, ÁÖ ¾àÇÐÀ§¿øÈ¸(State Board of Pharmacy)¿¡¼­ ¾à»ç ¸éÇ㠹߱ޠ¹× °»½Å µîÀÇ ÇàÁ¤¾÷¹«¸¦ ´ã´çÇÑ´Ù. °¢ ÁÖÀÇ ¾àÇÐÀ§¿øÈ¸´Â ¾à»ç¿¬¼ö±³À° ½Ã°£À» ÁöÁ¤Ç졒ʡ¨»çÇÑ´Ù. 

¿¬¼ö±³À° ÇÐÁ¡(CE credit)ÀÇ À̼ö ¿©ºÎµµ ¹«ÀÛÀ§ °¨»ç¸¦ ÅëÇØ ½ÃÇàÇϸç, Çʼö ÇÐÁ¡ÀÇ ¹Ì ÃæÁ· ½Ã¿¡´Â ¹ú±ÝÀ» ³»°Ô Çϰųª Â¡°è¸¦ ÇÑ´Ù. ÁÖº°·Î ¾à»ç¿¬¼ö±³À°¿¡ °üÇÑ À̼ö ÇÐÁ¡ ¹× ±â°£ÀÌ ´Ù¸£Áö¸¸ ´ëü·Î 1³â¿¡ 15½Ã°£ ÀüÈķΠ¿¬¼ö±³À°À» ½Ç½ÃÇϰԠµÇ¸ç, ¾à»ç ¸éÇã °»½Å°ú ¿¬°èµÅ ÀÖ´Ù.

ACPE´Â ¾à»ç °ü·Ã ±³À° °ü¸®¸¦ À§ÇÑ ¹Ì±¹ Á¤ºÎ ±â°üÀ¸·Î °íµî±³À°À§¿øÈ¸(Council for Higher Education Accreditation)¿¡ ÀÇÇØ °¨µ¶µÈ´Ù. ACPE´Â ¹Ì±¹¾àÇдëÇÐÇùÀÇȸ(American Association of College of Pharmacy), ¹Ì±¹¾à»çȸ(American Pharmaceutical Association), ¹Ì±¹¾à»ç ½ÉÀÇÀ§¿øÈ¸(National Association of Board of Pharmacy)°¡ °øµ¿À¸·Î ¿î¿µ¿¡ Âü¿©Çϰí ÀÖ´Ù. 

±¹¹Î ´ëÇ¥(Panel of Public Representative)°¡ Á¤Ã¥ °áÁ¤ µî¿¡ Âü°íÀÎ(Advisory) ÀÚ°ÝÀ¸·Î Çù·ÂÇÏÁö¸¸, ÀÚÀ²ÀûÀ̸砵¶¸³ÀûÀΠ±â°üÀ¸·Î ¿î¿µµÈ´Ù(Dimitra V. Travlos ¿Ü, 2017). ¶ÇÇÑ ACPE´Â 2019³â ÇöÀç 10¸íÀÇ ÀÌ»çÁø(Board of Directors)À¸·Î ±¸¼ºµÅ ÀÖÀ¸¸ç CPE Commission, International Commission, Pharmacy Technician Accreditation Commission(PTAC), Public Interest Panel(5³â ÀÓ±â)À» ÇÏÀ§ ±â±¸·Î µÎ°í ÀÖ´Ù. 

ACPEÀÇ ÁÖ¿ä ÀÓ¿ø Áß Àý¹Ý °¡·®Àº ¾à»ç(Pharm.D)·Î ±¸¼ºµÅ ÀÖ´Ù. ACPE´Â ¹Ì±¹ ³»¿¡¼­ °¡Àå ±ÇÀ§ Àִ ¾à»ç ±³À° ±â°üÀÇ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÇØ¿ÜÀÇ ¾àÇдëÇР¹× ¾à»ç¿¬¼ö±³À°ÀÇ Æò°¡ ¹× ÀÎÁõ¿¡µµ Âü¿©Çϰí ÀÖ´Ù.

¡â±³À° ¹æ¹ý ¹× ³»¿ë
¹Ì±¹ ¾à»ç¿¬¼ö±³À°Àº °øÀαâ°ü(Local/State/National Association)ÀÌ ¿î¿µÇϴ Á÷Á¢ Âü¿© ¿¬¼ö±³À°(Live Programs), °í¿ëÁÖ°¡ Á¦°øÇÏ´Â(Employer Sponsored) ¿¬¼ö±³À°, Á¦¾àȸ»ç¿¡¼­ Áö¿øÇÏ´Â(Industry Sponsored) ¿¬¼ö±³À°, ¼ö±â ÀÛ¼º ¹× È¸½Å ¹æ½Ä(Written/Correspondence)ÀÇ ¿¬¼ö±³À°, ÀǾ࠰ü·Ã Àú³Î Âü¿© ±³À°(Journals), ¿Â¶óÀΠ±³À°, ºñµð¿ÀÅ×ÀÌÇÁ³ª DVD¸¦ ÅëÇÑ ¿¬¼ö±³À° µîÀ¸·Î ±¸¼ºµÈ´Ù(Dimitra V. Travlos ¿Ü, 2017).

¾à»ç¿¬¼ö±³À°ÀÇ °ú¸ñÀ» »ìÆìº¸¸é, ¹Ì±¹ Åػ罺 ÁÖÀÇ °æ¿ì Á¶Á¦ ½Ç¼ö ¿¹¹æÀ» À§ÇÑ ½Ç½À, ÄÝ·¹½ºÅ×·Ñ Áúȯ, ´ç´¢ °ü·Ã ¾à¹°ÇÐ, ¾à±¹ Á¤º¸ÇР¹× ¾à»ç ¹ý±Ô, ¸é¿ªÇÐ, ¾ËÃ÷ÇÏÀ̸ÓÁúȯ µîÀÌ ¾à»çµéÀÌ ¼±È£Çϴ °ú¸ñÀÓÀ» ¾Ë ¼ö ÀÖ´Ù. 

°¢ °ú¸ñÀº ´Ù¾çÇѠȰµ¿À¸·Î ±¸¼ºµÅ ÀÖ¾î 2015³â ±âÁØÀ¸·Î 2¸¸9661°³ÀÇ CPE Activities°¡ Àִ °ÍÀ¸·Î È®ÀεƴÙ. 

1995³â Á¶»çµÈ ¹Ì±¹ ¾à»ç¿¬¼ö±³À°ÀÇ ÁÖÁ¦ÀΠ°¨¿°¼º Áúȯ/Ç×»ýÁ¦( 1À§), ½ÉÇ÷°ü°èÁúȯ/¾à¹°¿ä¹ý(2À§), OTC ¾à¹°¿ä¹ý(3À§), »ý»êÁ÷ ¾à»ç¸¦ À§ÇÑ °­ÁÂ(4À§)¿Í ºñ±³ÇØ º¼ ¶§ ½ÇÁ¦ ¾÷¹«¿¡ ÇÊ¿äÇÑ Á÷¹«´É·Â°ú À¯Ç༺ Áúº´ÀÇ º¯È­ µî ½Ã´ëÀÇ È帧¿¡ µû¶ó ±³À° °ú¸ñ¿¡µµ º¯È­°¡ ÀÖÀ½À» ¾Ë ¼ö ÀÖ´Ù.4)

¹Ì±¹Àº ¾à»ç±³À° ÈÄ ±³À°¿¡ ´ëÇÑ »çÈÄ Æò°¡°¡ Àǹ«È­µÅ ÀÖ´Ù. ±³À°¿¡ ´ëÇÑ ¸¸Á·µµ, ÀûÁ¤ ±³À°½Ã°£, °­»çÀÇ Áú, ±³À° ÀÚ·áÀÇ À¯¿ë¼º, »ó¾÷Àû ¿µÇ⠵ ´ëÇÑ Çǵå¹é °á°ú¸¦ Åä´ë·Î ¿¬¼ö±³À°ÀÇ ¹ßÀüÀ» µµ¸ðÇϰíÀÚ Çϴ °ÍÀÌ´Ù. 


±â»çÃâó: https://www.kpanews.co.kr/academy/show.asp?search_cate=8&idx=87


 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
9 [µ¥Àϸ®ÆÊ]¾à±¹ Á÷¿ø ¾÷¹«¹üÀ§ ÇØ¿Üµµ '±Ø°ú ±Ø'¡¦±¹³»´Â ¾î¶»°Ô? ±è¼±Èñ 2020-04-09 1140
8 [¾à»ç°ø·Ð]ÀǾàǰÁ¤Ã¥¿¬, Áö¿ª¾à±¹ ¸ðµ¨ ¿Ï¼º ³ë·Â¡¦Á¤±âÀÌ»çȸ °³ÃÖ ±è¼±Èñ 2020-04-09 736
7 [µ¥Àϸ®ÆÊ]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ¿Â¶óÀÎ ÀÌ»çȸ ¿­°í »ç¾÷ È®Á¤ ±è¼±Èñ 2020-04-09 753
6 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 4 ±è¼±Èñ 2020-04-09 721
5 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 3 ±è¼±Èñ 2020-04-09 627
4 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 2 ±è¼±Èñ 2020-03-24 737
3 [ÄíŰ´º½º]WHO, Àü¼¼°è ¸¶½ºÅ© »ý»ê·® 40% Áõ°¡ ÇÊ¿ä ±è¼±Èñ 2020-03-16 1226
2 [´ëÇѾà»çÀú³Î]¹Ì±¹, ½Ã´ë ¸ÂÃç ±³À°°ú¸ñ º¯È­¡¦»çÈÄÆò°¡µµ Àǹ«È­ ±è¼±Èñ 2020-03-16 923
1 [´ëÇѾà»çÀú³Î]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®: Ä¿¹Â´ÏƼÄɾî, ¼¼°èÀÇ ´äÀº ¡®¾à»ç¡¯¿´´Ù ±è¼±Èñ 2020-03-10 981

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»